Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 70/100

Failure Rate

50.0%

3 terminated/withdrawn out of 6 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

33%

2 trials in Phase 3/4

Results Transparency

67%

2 of 3 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

N/A

4(66.7%)

Phase 3

2(33.3%)

6Total

N/A(4)

Phase 3(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT01810679Not ApplicableTerminated

Perceval S Aortic Heart Valve Study- North America

Role: lead

NCT01115907Phase 3Completed

Freedom SOLO Stentless Heart Valve Study

Role: lead

NCT00567853Phase 3Completed

Safety and Efficacy Study of the Sorin 3D Annuloplasty Ring For Mitral Repair

Role: lead

NCT00705913Not ApplicableTerminated

Randomized Sizing and Hemodynamic Study Mitroflow vs. Magna

Role: lead

NCT00619151Not ApplicableTerminated

CarboMedics Top Hat vs St. Jude Medical Regent Valve Comparing Sizing and Hemodynamics

Role: lead

NCT00630916Not ApplicableCompleted

Clinical Investigation Of The Mitroflow Aortic Pericardial Heart Valve

Role: lead

All 6 trials loaded